Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulinastatin for prevention of complications after pancreaticoduodenectomy
ChiCTR-TRC-12002160Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of ulinastatin in complications of surgical procedures and Systemic Inflammatory Response Syndrome (SIRS) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Incidence rate of complications. Started Jun 2012; status: completed.
02
Drugs
ulinastatin
03
Conditions
complications of surgical proceduresSystemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on ChiCTR-TRC-12002160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002160.